Ectodermal Dysplasia clinical trials
The registry lists 26 studies for Ectodermal Dysplasia across 9 countries. 8 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-04-15.
Status
- Completed
- 15
- Recruiting
- 7
- Enrolling by invitation
- 1
- Active, not recruiting
- 1
- Terminated
- 1
- Withdrawn
- 1
Phase
- Phase 2
- 2
- Phase 1
- 1
Where
- United States
- 18
- Germany
- 7
- France
- 5
- Italy
- 4
- United Kingdom
- 4
- Netherlands
- 2
Who runs them
Edimer Pharmaceuticals (12) · University Hospital Erlangen (3) · Maastricht University Medical Center (2) · Sanford Health (1) · EspeRare Foundation (1) · Dermelix Biotherapeutics, LLC. (1) · UConn Health (1) · National Institute of Dental and Craniofacial Research (NIDCR) (1)
Studies
Recruiting first, then most recently updated. Showing 26 of 26 — search for more.
- Genetic and Functional Analysis of Aplasia Cutis Congenital (ACC)RecruitingNCT016304211 country
- Organization's Unique Protocol IDRecruitingNCT07468019Not applicable1 country
- FARD (RaDiCo Cohort) (RaDiCo-FARD)RecruitingNCT059544161 country
- CDH1-associated Blepharocheilodontic Syndrome RegistryRecruitingNCT071334641 country
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT017931682 countries
- Reproductive Options in Inherited Skin DiseasesEnrolling by invitationNCT063303241 country
- Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive CounsellingRecruitingNCT063303501 country
- Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal DysplasiaRecruitingNCT04980638Phase 26 countries
- Short Term Effects and Risks of Physical Exercise in Subjects With Hypohidrotic Ectodermal DysplasiaCompletedNCT011358881 country
- Pediatric SARS-CoV-2 Infections: Course of COVID-19, Immune Responses, Complications and Long-term ConsequencesCompletedNCT047414121 country
- A Cross-Sectional Natural History Study to Evaluate Sweat Volume and Other Phenotypic and Genetic Characteristics in Patients Affected by XLHEDWithdrawnNCT039127921 country
- Studies of Disorders in Antibody Production and Related Primary Immunodeficiency StatesTerminatedNCT002665131 country
- Extension Study of XLHED-Affected Male Subjects Treated With EDI200 in Protocol ECP-002Active, not recruitingNCT019922895 countries
- Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal DysplasiaCompletedNCT020995525 countries
- Phase 2 Study to Evaluate Safety, Pharmacokinetics, Immunogenicity and Pharmacodynamics/Efficacy of EDI200 in Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)CompletedNCT01775462Phase 25 countries
- A Phase 1, Open-label, Multicenter, Safety and Pharmacokinetic Study of EDI200CompletedNCT01564225Phase 11 country
- Phenotypic Properties in Individuals Affected With XLHEDCompletedNCT018717141 country
- X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) Carrier Outlook Toward Reproduction SurveyCompletedNCT013988131 country
- Phenotypic and Genetic Properties in Males at Risk for X-linked Hypohidrotic Ectodermal Dysplasia: Evaluation of an Early Diagnosis Technology and Tests to Assess Nutritional StatusCompletedNCT016299401 country
- Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal DysplasiaCompletedNCT011087701 country
- Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected by Hypohidrotic Ectodermal Dysplasia - ACompletedNCT012935651 country
- Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia (ECP-012)CompletedNCT016299271 country
- Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia: Intrafamilial VariationCompletedNCT013867751 country
- Medical Record Review of Hypohidrotic Ectodermal Dysplasia Clinical PhenotypeCompletedNCT013983971 country
- Characterization of Sweat Gland Function in Patients With Recessively Inherited Hypohidrotic Ectodermal DysplasiaCompletedNCT011092901 country
- Clinical Study of Oral Endosseous Titanium Implants in Edentulous SubjectsCompletedNCT000012111 country